| For: | Teixeira MF, Borad M, Serrano Uson Junior PL. Circulating tumor DNA in biliary tract cancers: A review of current applications. World J Clin Oncol 2025; 16(10): 107875 [PMID: 41178929 DOI: 10.5306/wjco.v16.i10.107875] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8470/full/v16/i10/107875.htm |
| Number | Citing Articles |
| 1 |
Lorenzo Manganaro, Giuseppe De Sario, Guido Carpino, Lewis J. Frey, Eugenio Gaudio, Wing-Kin Syn, Domenico Alvaro, Vincenzo Cardinale. Digital and Biological Twins in Cholangiocarcinoma: From Translational Research to Precision Medicine—A Narrative Review. Livers 2026; 6(4) doi: 10.3390/livers6040080
|
| 2 |
Khalil Choucair, Shadi Chamseddine, Asfar Azmi, Philip A. Philip. Advancing systemic therapy for biliary tract cancer: current strategies and emerging paradigms. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1769447
|
| 3 |
Jingnan Xue, Longhao Zhang, Kai Zhang, Yu Wu, Kai Zhou, Xin Lu. Metabolic collusion driving immune evasion in cholangiocarcinoma: unmasking the dual control of the immuno-metabolic microenvironment. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1697056
|
| 4 |
Haixing Wei, Jie Wang, Qing Wu, Mengbin Qin. Circulating Tumor DNA in Cholangiocarcinoma: A Precision Oncology Roadmap. Cancer Management and Research 2026; doi: 10.2147/CMAR.S574678
|
| 5 |
Nan Yao, Wenqiang Li, Ning Duan, Fuzhou Han, Guoyong Yu, Jun Qu. Practical integration of ctDNA-defined minimal residual disease in gastrointestinal cancers: testing windows and evidence-aligned management frameworks. Clinical and Translational Oncology 2026; doi: 10.1007/s12094-026-04405-6
|
| 6 |
Xuewu Zhang, An Jiang. Endobiliary Photodynamic Therapy in Cholangiocarcinoma: Clinical Outcomes, Patient Selection, and Procedural Context. Current Oncology 2026; 33(6) doi: 10.3390/curroncol33060343
|
| 7 |
Rabia Zahid Bukhari, Zhenghua Li, Fuyu Li, Haijie Hu. Translational and Implementation Barrier in the Management of Biliary Tract Cancer: Diagnostic, Molecular, Therapeutic, and Patient‐Centered Challenges. Journal of Gastroenterology and Hepatology 2026; 41(9) doi: 10.1111/jgh.70534
|
| 8 |
Linda Bartalini, Margherita Rimini, Masafumi Ikeda, Oluseyi Abidoye, Jessica Lucchetti, Lorenzo Antonuzzo, Jin Won Kim, Arndt Vogel, Angela Lamarca, Federico Nichetti, Anna Saborowski, Tiziana Pressiani, Caterina Vivaldi, Ilario Giovanni Rapposelli, Jeroen Dekervel, Chiara Braconi, David James Pinato, Emiliano Tamburini, Chiara Carlotta Pircher, Stefano Tamberi, Florian Castet, Monica Verrico, Alessandro Parisi, Nuno Couto, Hong Jae Chon, Andrea Martirena, Matteo Landriscina, Fabian Finkelmeier, Ester Oneda, Antonio Avallone, Emanuela Dell’Aquila, Lukas Perkhofer, Il Hwan Kim, Vincenzo Formica, Cidalia Maria de Sousa Pinto, Ingrid Garajova, Beodeul Kang, Salvatore Corallo, Elisabetta Fenocchio, Giovanni Farinea, Alessandro Pastorino, Anna Diana, Changhoon Yoo, Marta Schirripa, Maria Grazia Rodriquenz, Mario Scartozzi, Lucrezia Zumstein, Michele Ghidini, Gerald W. Prager, Giuseppe Aprile, Gian Paolo Spinelli, Yung-Yeh Su, Stephen L. Chan, Emily Warmington, Alessia Lancianese, Tomoyuki Satake, Tanios Bekaii-Saab, Daniele Lavacchi, Laura Passeri, Michele Ferrara, Minsu Kang, Alessandra Anna Prete, Silvia Bozzarelli, Mara Persano, Andrea Pretta, Gianluca Masi, Rita Balsano, Monica Niger, Sara Lonardi, Francesca Salani, Silvia Camera, Lorenzo Fornaro, Andrea Casadei-Gardini, Lorenza Rimassa. Prognostic Role of Adverse Events in a Worldwide Population of Patients with Biliary Tract Cancer Treated with Chemo-Immunotherapy. Cancers 2026; 18(18) doi: 10.3390/cancers18182921
|